Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer

Bibliography

• Jemal A, Siegel R, Ward E, Cancer statistics. CA Cancer J Clin 2009;59:225-4
   PubMed Web of Science ®Google Scholar
• Greenwald P, Kelloff GJ. The role of chemoprevention in cancer control. IARC Sci 1996;139:13-22
   PubMedGoogle Scholar
• Kawamori T, Lubet R, Steele VE, Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999;59:597-601
   PubMed Web of Science ®Google Scholar
• Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005;41:1955-68
   PubMed Web of Science ®Google Scholar
• Ringman John M, Frautschy Sally A, Cole Gregory M, Potential role of the curry spice curcumin in Alzheimer's disease. L. Curr Alzheimer Res 2005;2:131-6
   PubMedGoogle Scholar
• Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 1999;19:3675-80
   PubMed Web of Science ®Google Scholar
• Surh YJ, Chun KS, Cha HH, Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa beta activation. Mutat Res 2001;480-481:243-68
   PubMed Web of Science ®Google Scholar
• Jaiswal AS, Marlow BP, Gupta N, Narayan S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 2002;21:8414-27
   PubMed Web of Science ®Google Scholar
• Lev-Ari S, Strier L, Kazanov D, Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 2005;11:6738-44
   PubMed Web of Science ®Google Scholar
• Lev-Ari S, Zinger H, Kazanov D, Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomed Pharmacother 2005;59:S276-80
   PubMed Web of Science ®Google Scholar
• Lev-Ari S, Strier L, Lichtenberg D, Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford) 2006;45:171-7
   PubMed Web of Science ®Google Scholar
• Shpitz B, Giladi N, Sagiv E, Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion 2006;74:140-4
   PubMed Web of Science ®Google Scholar
• Shen TY, Winter CA. Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 1977;12:90-245
   PubMedGoogle Scholar
• Exisulind: aptosyn, FGN 1, prevatac, sulindac sulfone. Drugs R D 2004;5:220-6
   PubMedGoogle Scholar
• Thompson HI, Briggs S, Paranka NS, Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Nat Cancer Inst 1995;87:1259-260
   PubMed Web of Science ®Google Scholar
• Reddy BS, Kawamori T, Lubet RA. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res 1999;59:3387-91
   PubMed Web of Science ®Google Scholar
• Kim KP, Whitehead C, Piazza G, Wargovich MJ. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci. Anticancer Res 2004;24:1805-11
   PubMed Web of Science ®Google Scholar
• Thompson HJ, Jiang C, Lu J. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res 1997;57:267-71
   PubMed Web of Science ®Google Scholar
• Goldberg Y, Nassif II, Pittas A. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 1996;12:893-901
   PubMed Web of Science ®Google Scholar
• Burke C, van Stolk R, Arber N, Exisulind prevents adenoma formation in familial adenomatous polyposis (FAP). Gastroenterology 2000;118:A657
   Web of Science ®Google Scholar
• Arber N, Kuwada S, Leshno M, Exisulind Study Group. Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study. Gut 2006;55:367-73
   PubMed Web of Science ®Google Scholar
• Arber N, Sutter T, Miyake M, Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 1996;12:1903-8
   PubMedGoogle Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51
   PubMed Web of Science ®Google Scholar
• Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-51
   PubMed Web of Science ®Google Scholar
• Torrance CJ, Jackson PE, Montgomery E, Combinatorial chemoprevention of intestinal neoplasia. Nat Med 2000;6:1024-8
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847-54
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363-98
   PubMed Web of Science ®Google Scholar
• Cruz-Correa M, Shoskes DA, Sanchez P, Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006;4:1035-8
   PubMed Web of Science ®Google Scholar
• Piazza GA, Alberts DS, Hixson LJ, Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997;57:2909-15
   PubMed Web of Science ®Google Scholar
• Minami T, Adachi M, Kawamura R, Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity. Clin Cancer Res 2005;11:5248-56
   PubMed Web of Science ®Google Scholar
• Ohishi T, Kishimoto Y, Miura N. Synergistic effects of (−) epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett 2002;177:49-56
   PubMed Web of Science ®Google Scholar
• Chan DC, Earle KA, Zhao TL. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res 2002;8:904-12
   PubMed Web of Science ®Google Scholar
• Soriano AF, Helfrich B, Chan DC, Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res 1999;59:6178-84
   PubMed Web of Science ®Google Scholar